Identifying new pathways to treat cardiovascular disease
The Heart Research Institute (HRI) is conducting a collaborative research project with the University of Cambridge to investigate new pathways to treat cardiovascular disease.
Pesky bush ticks could be key to saving lives in world-first HRI research
HRI is on the cusp of developing a drug to save people from deadly strokes using a common Australian bush tick.
DECRA and Vanguard Grant awarded to Dr Xuyu Liu
Dr Xuyu Liu was awarded a 2022 Discovery Early Career Researcher Award as well as a Heart Foundation 2022 Vanguard Grant.
HRI wins RACI Women in Chemistry Honourable Prize
Congratulations to PhD student Ivy Guan on being awarded the Women in Chemistry Honourable Prize at RACI2022.
Discovering why stiff heart failure affects more women than men
HRI is investigating why more women than men are affected by heart failure with preserved ejection fraction.
HRI scientists working to prove how some of the most unpopular vegetables could reverse stroke
HRI has discovered cruciferous veg like Brussels sprouts and broccoli can help dissolve blood clots and improve the performance of clot-busting drugs, which could help treat stroke.
Inspiration from natural products in heart-healthy diets used to fight cardiovascular disease
HRI’s Dr Xuyu Liu is researching how healthy heart diets that contain ‘natural products’ can give rise to new treatments for thrombosis.
New COO for the Heart Research Institute
HRI is pleased to announce that Dr Tim Gainsford has been appointed Chief Operating Officer from Monday, 5 September 2022.
Investigating platelet hyperactivity in diabetes for preventative therapies
HRI is conducting a collaborative research project investigating the mechanisms of platelet hyperactivity in diabetes with Dr Maggie Kalev-Zylinska, University of Auckland.